Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
04/1998
04/15/1998EP0835114A1 Pharmaceutical combined preparation, kit and method for hormonal contraception
04/15/1998CN1178690A Gynecological external use capsule
04/14/1998US5739345 Intermediate compounds in the preparation of heterocyclic compounds having anti-diabetic activity
04/14/1998US5739138 Modulators of cellular response
04/14/1998US5739137 Enzyme inhibitor treating skin disorder, hair baldness, glandular disorder and prostatic hyperplasia
04/10/1998CA2217810A1 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods
04/10/1998CA2217373A1 Benzo¬b|thiophene compounds, intermediates, formulations, and methods
04/10/1998CA2217235A1 Benzo¬b|thiophene compounds, intermediates, formulations, and methods
04/10/1998CA2217135A1 Benzo-b-thiophene compounds, intermediates, formulations, and methods
04/09/1998WO1998014568A1 Human growth gene and short stature gene region
04/09/1998WO1998014203A1 A method and compositions for treatment of insulin-dependant diabetes mellitus
04/09/1998CA2647169A1 Human growth gene and short stature gene region
04/09/1998CA2267097A1 Human growth gene and short stature gene region
04/09/1998CA2267063A1 A method and compositions for treatment of insulin-dependant diabetes mellitus
04/08/1998EP0833909A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
04/08/1998EP0833845A1 Compounds with growth hormone releasing properties
04/08/1998EP0833822A1 4-phenylaminothiazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives
04/08/1998EP0833650A1 P-selectin ligands and related molecules and methods
04/08/1998EP0833646A1 Multi-tyrosinated somatostatin analogs
04/08/1998EP0833642A1 Compressed dry-granulation desogestrel tablets
04/08/1998EP0833620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
04/08/1998EP0512042B1 Glp-1 analogs useful for diabetes treatment
04/01/1998EP0832069A1 BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION
04/01/1998EP0831866A1 Pineal gland specific gene-1
04/01/1998EP0831824A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
04/01/1998EP0831787A2 Composition for sustained release of human growth hormone
04/01/1998EP0831769A2 Novel uses for thyroid hormones or thyroid hormone-like compounds
03/1998
03/31/1998US5734026 Process for manufacturing crystals of growth hormone and crystals thereby obtained
03/31/1998US5733565 Male contraceptive implant
03/26/1998WO1998012224A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
03/26/1998WO1998011884A1 Use of sibutramine analogues to prevent the development of diabetes
03/26/1998CA2266585A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
03/25/1998EP0830372A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
03/25/1998EP0830138A1 Use of fibroblast growth factors to stimulate bone growth
03/25/1998EP0830136A1 New cryptophycins from synthesis
03/25/1998EP0628040B1 Indole derivatives as steroid 5 alpha-reductase inhibitors
03/25/1998CN1177295A Method of inhibiting growth hormone effects
03/24/1998US5731332 Leukotriene antagonists; antiinflammatory agents, antiallergens
03/24/1998US5731328 Administering 2-phenyl-3-aroylbenzothiophene compounds to a patient
03/24/1998US5731327 Synthesis of 3- 4-(2-aminoethoxy)benzoyl!-2-aryl-6-hydroxybenzo b!thiophenes
03/19/1998WO1998011109A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/19/1998WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998WO1998010781A1 Means for treating prostate hypertrophy and prostate cancer
03/19/1998WO1998010753A1 Captopril tablets
03/19/1998CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998CA2237314A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/18/1998EP0829011A1 Inhibition of amylin release
03/18/1998EP0828758A1 Chimeric fatty body-pro-grf analogs with increased biological potency
03/18/1998EP0828754A1 Dipeptides which promote release of growth hormone
03/17/1998US5728819 Secreted proteins and polynucleotides encoding them
03/17/1998US5728724 Treatment of postmenopause syndrome, osteoporosis, cardiovascular disorders and estrogen dependent cancer
03/17/1998US5728688 Therapeutic methods and delivery systems utilizing sex steroid precursors
03/12/1998WO1998009619A1 Novel methods
03/12/1998WO1998009519A1 Method of treating post menopausal diseases, including osteoporosis
03/12/1998CA2264943A1 Novel methods
03/12/1998CA2264775A1 Method of treating post menopausal diseases, including osteoporosis
03/12/1998CA2215015A1 Treating prostate hypertrophy and prostate cancer
03/10/1998US5726186 For treating post-menopausal syndrome, uterine fibroid disease, endometriosis and aortal smooth muscle cell proliferation
03/05/1998WO1998008871A1 Glp-1 derivatives
03/05/1998WO1998008855A2 N6 heterocyclic substituted adenosine derivatives
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008846A1 Substituted 6,6-hetero-bicyclic derivatives
03/05/1998WO1998008797A1 Naphthyl compounds, intermediates, compositions, and methods of use
03/05/1998WO1998008525A1 Process to obtain oestrogens from mare's urine
03/05/1998WO1998008503A1 Therapeutic methods and compositions involving isoflavones
03/05/1998CA2265049A1 Therapeutic methods and compositions involving isoflavones
03/04/1998EP0826680A1 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
03/04/1998EP0826679A2 Naphthyl compounds, intermediates, compositions, and method of use
03/04/1998EP0826670A1 Naphthalene compounds, intermediates, formulations, and methods
03/04/1998EP0825885A1 Pulmonary delivery of aerosolized medicaments
03/04/1998EP0825865A1 Transdermal therapeutic system for administering testosterone
03/04/1998CN1175247A Steroid receptor modulator compounds and methods
03/04/1998CN1174845A Method for synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide
03/04/1998CN1174709A Traditional Chinese set prescription for curing gastrointestinal tract disease and gynopathy
03/03/1998US5723577 Analogs of parathyroid hormone
03/03/1998US5723476 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
03/03/1998US5723474 Benzothiophene compounds, intermediates, compositions, and methods
03/03/1998US5723343 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor
02/1998
02/28/1998CA2213814A1 Naphthalene compounds, intermediates, formulations, and methods
02/26/1998WO1998007855A2 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007740A1 7α-(κ-AMINOALKYL)ESTRATRIENES, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 7α-(κ-AMINOALKYL)ESTRATRIENES AND THEIR USE FOR PREPARING MEDICAMENTS
02/26/1998WO1997039123A3 Secreted proteins
02/26/1998DE19635525A1 New 7-alpha-(xi-aminoalkyl)- oestratriene derivatives
02/26/1998CA2263708A1 7.alpha.-(.xi.-aminoalkyl)estratrienes, process for preparing the same, pharmaceutical preparations containing said 7.alpha.-(.xi.-aminoalkyl)-estratrienes and their use for preparing medicaments
02/26/1998CA2263192A1 Secreted proteins and polynucleotides encoding them
02/25/1998CN1174058A Medicine powder for hyperthyroidism and its preparation
02/18/1998CN1173497A Heterocycle-containing carbonic acid derivatives
02/17/1998US5719158 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
02/17/1998US5719137 Method of preventing neurodegeneration and cognitive dysfunction using 17α-dihydroequilenin
02/12/1998WO1998005780A2 Voltage-gated calcium channel antagonist and methods
02/12/1998WO1998005776A2 Secreted proteins and polynucleotides encoding them
02/12/1998WO1998005661A1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
02/12/1998WO1998005352A1 Hypothalamus-specific polypeptides
02/12/1998DE19652183C1 Treating oestrogen-dependent tumour with Cimicifuga racemosa extract
02/12/1998CA2262753A1 Voltage-gated calcium channel antagonist and methods
02/12/1998CA2262399A1 Secreted proteins and polynucleotides encoding them
02/12/1998CA2261565A1 Hypothalamus-specific polypeptides
02/11/1998EP0822814A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
02/11/1998CN1172811A Insulin derivatives with increased zinc binding
02/10/1998US5717088 Method of making steroid derivatives for the treatment of prostatic hypertrophy
1 ... 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 ... 290